Mark A. Goldsmith - Oct 11, 2024 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Stock symbol
RVMD
Transactions as of
Oct 11, 2024
Transactions value $
-$1,388,073
Form type
4
Date filed
10/15/2024, 05:30 PM
Previous filing
Oct 3, 2024
Next filing
Nov 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $123K +30K +9.99% $4.09 330K Oct 11, 2024 Direct F1, F2
transaction RVMD Common Stock Sale -$1.51M -30K -9.09% $50.36 300K Oct 11, 2024 Direct F1, F2, F3
holding RVMD Common Stock 25.4K Oct 11, 2024 Trust F4
holding RVMD Common Stock 25.4K Oct 11, 2024 Trust F5
holding RVMD Common Stock 466K Oct 11, 2024 Trust F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -30K -11.06% $0.00 241K Oct 11, 2024 Common Stock 30K $4.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023.
F2 Includes 188,750 restricted stock units.
F3 This transaction was executed in multiple trades in prices ranging from $50.00 to $50.82, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 Held by Jonathan Goldsmith Revocable Trust.
F5 Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F6 Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.

Remarks:

President and Chief Executive Officer